0001752724-20-226909.txt : 20201113 0001752724-20-226909.hdr.sgml : 20201113 20201112202610 ACCESSION NUMBER: 0001752724-20-226909 CONFORMED SUBMISSION TYPE: N-CEN PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20200831 FILED AS OF DATE: 20201113 DATE AS OF CHANGE: 20201112 EFFECTIVENESS DATE: 20201113 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BLACKROCK MASSACHUSETTS TAX-EXEMPT TRUST CENTRAL INDEX KEY: 0000901824 IRS NUMBER: 043196366 FILING VALUES: FORM TYPE: N-CEN SEC ACT: 1940 Act SEC FILE NUMBER: 811-07660 FILM NUMBER: 201308806 BUSINESS ADDRESS: STREET 1: 100 BELLEVUE PARKWAY CITY: WILMINGTON STATE: DE ZIP: 19809 BUSINESS PHONE: 800-441-7762 MAIL ADDRESS: STREET 1: 100 BELLEVUE PARKWAY CITY: WILMINGTON STATE: DE ZIP: 19809 FORMER COMPANY: FORMER CONFORMED NAME: MASSACHUSETTS HEALTH & EDUCATION TAX EXEMPT TRUST DATE OF NAME CHANGE: 19950908 N-CEN 1 primary_doc.xml X0303 N-CEN LIVE 0000901824 XXXXXXXX 811-07660 false false false N-2 BlackRock Massachusetts Tax-Exempt Trust 811-07660 0000901824 JVXKX2T5M1HV3N3HNM13 100 Bellevue Parkway Wilmington 19809 US-DE US 800-441-7762 State Street Bank and Trust Company 1 Lincoln Street Boston 02111 617-786-3000 Records related to its functions as custodian, sub-administrator and accounting agent BlackRock Investments, LLC 40 East 52nd St New York 10022 609-282-3046 Records related to its functions as distributor Computershare Trust Company, National Association 250 Royall Street Canton 02021 781-575-2000 Records related to its functions as transfer agent BlackRock Advisors, LLC 100 Bellevue Parkway Wilmington 19809 302-797-2000 Records related to its functions as advisor and administrator N N N-2 Y Richard E. Cavanagh 000000000 N Catherine A. Lynch 000000000 N Robert Fairbairn 004992372 Y Frank J. Fabozzi 000000000 N R. Glenn Hubbard 000000000 N W. Carl Kester 000000000 N Karen P. Robards 000000000 N Michael J. Castellano 000000000 N John M. Perlowski 000000000 Y Cynthia L. Egan 000000000 N Charles Park 000000000 55 East 52nd Street New York 10055 XXXXXX N N N N N BlackRock Investments, LLC 8-48436 000038642 54930061FBHCKXL2G714 Y N Deloitte & Touche LLP 34 00000000000000000000 N N N N N N BlackRock Massachusetts Tax-Exempt Trust JVXKX2T5M1HV3N3HNM13 N 0 0 0 N/A Y N Y N BlackRock Investment Management, LLC 5493006MRTEZZ4S4CQ20 Y N Revenue sharing split Other Cash collateral reinvestment fee Rebates paid to borrowers N/A N/A Rule 12d1-1 (17 CFR 270.12d1-1) Rule 22d-1 (17 CFR 270.22d-1) Rule 32a-4 (17 CFR 270.32a-4) Y Y N N BlackRock Advisors, LLC 801-47710 000106614 5493001LN9MRM6A35J74 N Computershare Trust Company, National Association 85-11340 2549001YYB62BVMSAO13 N N N Bloomberg L.P. 549300B56MD0ZC402L06 N ICE Data Services, Inc. 13-3668779 Tax ID N IHS Markit Ltd. 549300HLPTRASHS0E726 GB N Refinitiv US Holdings Inc. 549300NF240HXJO7N016 N N State Street Bank and Trust Company 571474TGEMMWANRLN572 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) Bofa Securities, Inc. 549300HN4UKV1E2R3U73 N Y Futures commission merchants and commodity clearing organizations - rule 17f-6 (17 CFR 270.17f-6) Credit Suisse Securities (USA) LLC 1V8Y6QCX6YMJ2OELII46 N Y Futures commission merchants and commodity clearing organizations - rule 17f-6 (17 CFR 270.17f-6) Goldman Sachs & Co. LLC FOR8UP27PHTHYVLBNG30 N Y Futures commission merchants and commodity clearing organizations - rule 17f-6 (17 CFR 270.17f-6) N N State Street Bank and Trust Company 571474TGEMMWANRLN572 N Y BlackRock Advisors, LLC 5493001LN9MRM6A35J74 Y N N BlackRock Execution Services 8-48719 000039438 549300HFCRQ0NT5KY652 0.00000000 BlackRock Investments, LLC 8-48436 000038642 54930061FBHCKXL2G714 0.00000000 Bofa Securities, Inc. 8-69787 000283942 549300HN4UKV1E2R3U73 320.24000000 320.24000000 Morgan Stanley & Co. LLC 8-15869 000008209 9R7GPTSO7KV3UQJZQ078 515480.00000000 BlackRock Liquidity Funds - MuniCash N/A 000000000 549300RWBJ885673DL84 21306601.93000000 UBS Securities LLC 8-22651 000007654 T6FIZBDPKLYJKFCRVK44 1149410.00000000 BNY Mellon Capital Markets, LLC 8-35255 000017454 VJW2DOOHGDT6PR0ZRO63 540912.50000000 Pershing LLC 8-17574 000007560 ZI8Q1A8EI8LQFJNM0D94 1127379.75000000 RBC Capital Markets, LLC 8-45411 000031194 549300LCO2FLSSVFFR64 750000.00000000 J.P. Morgan Securities LLC 8-35008 000000079 ZBUT11V806EZRVTWT807 1029664.25000000 BB&T Securities, LLC 8-67486 000142785 2549000IB2PRJ20M2Q93 573171.05000000 Citigroup Global Markets Inc. 8-8177 000007059 MBNUM2BPBDO7JBLYG310 2220960.00000000 Bofa Securities, Inc. 8-69787 000283942 549300HN4UKV1E2R3U73 1961627.50000000 31175206.98000000 N 34063103.21000000 Common stock BlackRock Massachusetts Tax-Exempt Trust Preferred stock Variable Rate Demand Preferred Shares N N N N N N 0.50000000 2.64000000 13.24000000 13.68000000 true true INTERNAL CONTROL RPT 2 NCEN_4452833591101390.txt REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the Shareholders and Board of Directors/Trustees of BlackRock Maryland Municipal Bond Trust, BlackRock Massachusetts Tax-Exempt Trust, BlackRock MuniHoldings New York Quality Fund, Inc., BlackRock New York Municipal Bond Trust, BlackRock New York Municipal Income Quality Trust, BlackRock New York Municipal Income Trust II, and BlackRock Virginia Municipal Bond Trust: In planning and performing our audits of the financial statements of BlackRock Maryland Municipal Bond Trust, BlackRock Massachusetts Tax-Exempt Trust, BlackRock MuniHoldings New York Quality Fund, Inc., BlackRock New York Municipal Bond Trust, BlackRock New York Municipal Income Quality Trust, BlackRock New York Municipal Income Trust II, and BlackRock Virginia Municipal Bond Trust (the "Funds"), as of and for the year ended August 31, 2020, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), we considered the Funds' internal control over financial reporting, including controls over safeguarding securities, as a basis for designing our auditing procedures for the purpose of expressing our opinion on financial statements and to comply with the requirements of Form N-CEN, but not for the purpose of expressing an opinion on the effectiveness of the Funds' internal control over financial reporting. Accordingly, we express no such opinion. The management of the Funds is responsible for establishing and maintaining effective internal control over financial reporting. In fulfilling this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of controls. A company's internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company's internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of a company's assets that could have a material effect on the financial statements. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions or that the degree of compliance with the policies or procedures may deteriorate. A deficiency in internal control over financial reporting exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company's annual or interim financial statements will not be prevented or detected on a timely basis. Our consideration of the Funds' internal control over financial reporting was for the limited purpose described in the first paragraph and would not necessarily disclose all deficiencies in internal control that might be material weaknesses under standards established by the PCAOB. However, we noted no deficiencies in the Funds' internal control over financial reporting and its operation, including controls for safeguarding securities that we consider to be a material weakness, as defined above, as of August 31, 2020. This report is intended solely for the information and use of management and Board of Directors/Trustees of the Funds and the Securities and Exchange Commission and is not intended to be and should not be used by anyone other than these specified parties. Deloitte & Touche LLP Boston, Massachusetts October 21, 2020 MATERIAL AMENDMENTS 3 NCEN_2828159580811770.htm mhe-g1biq12020.htm - Generated by SEC Publisher for SEC Filing

BLACKROCK MASSACHUSETTS TAX-EXEMPT TRUST

(THE “FUND”)

SERIES W-7

VARIABLE RATE DEMAND PREFERRED SHARES (“VRDP SHARES”)

CUSIP No. 09258E 208

Amendment to Notice of Special Rate Period

May 19, 2020

BlackRock Massachusetts Tax-Exempt
Trust
100 Bellevue Parkway
Wilmington, Delaware 19809

To: Addressees listed on Schedule 1 hereto

In accordance with the Fund’s Amended and Restated Certificate of Designation

Establishing and Fixing the Rights and Preferences of Variable Rate Demand Preferred Shares, dated June 17, 2019 (the “Certificate of Designation”), the Fund hereby notifies the Liquidity Provider, the Remarketing Agent and the Holders of the VRDP Shares that the last day of the Special Rate Period has been extended from June 17, 2020 to June 17, 2021 in accordance with the terms of the Amended and Restated Notice of Special Rate Period, dated June 19, 2019 (the “Notice of Special Rate Period”).

     The last day of the Special Rate Period shall be June 17, 2021, or such later date as the Special Rate Period may be extended pursuant to the terms of the Notice of Special Rate Period.

     As of May 19, 2020, the section entitled “Special Redemption Provisions” in the Notice of Special Rate Period is hereby deleted in its entirety.

     Capitalized terms used but not defined in this Amendment to Notice of Special Rate Period shall have the meanings given to such terms in the Certificate of Designation and the Notice of Special Rate Period.

[Signature Page Follows]

NOTE: Neither the Fund nor the Tender and Paying Agent shall be responsible for the selection or use of the CUSIP Numbers selected, nor is any representation made as to its correctness indicated in any notice or as printed on any VRDP Share certificate. It is included solely as a convenience to Holders of VRDP Shares.


 

IN WITNESS WHEREOF, I have signed this Amendment to the Notice of Special Rate Period as of the date first written above.

BlackRock Massachusetts Tax-Exempt Trust

By: /s/ Jonathan Diorio

Name: Jonathan Diorio

Title: Vice President

[Signature Page – MHE Amendment to Notice of Special Rate Period]


 

Schedule 1

Recipients of this Notice of Special Rate Period

Wells Fargo Bank, National Association 375 Park Avenue New York, NY 10152 Attention: Adam Joseph Telephone: (212) 214-5502 Facsimile: (212) 214-8971 Email: adam.joseph@wellsfargo.com

Wells Fargo Securities LLC MAC D1086-051

550 South Tryon Street, Charlotte, NC 28202 Attention: Jeffrey Gass/Carolyn Hurley

Email: jeffrey.gass@wellsfargo.com/carolyn.hurley@wellsfargo.com The Depository Trust Company LensNotice@dtcc.com